BioSig Technologies, Inc. announces its intention to offer shares of common stock through an underwritten public offering.
The company plans to use the net proceeds for purchasing gold bullion, working capital, and general corporate purposes.
Clear Street and Needham & Company are the joint book-running managers of the offering.
Proposed Public Offering
Shares of common stock to be offered through underwritten public offering.
Use of Proceeds
Net proceeds to be used for purchasing gold bullion, working capital, and general corporate purposes.
Book-Running Managers
Clear Street and Needham & Company are acting as joint book-running managers of the offering.
- The completion of the offering is subject to market conditions.
- No assurance regarding the timing, size, or terms of the offering.
Interested parties should read all relevant documents filed with the SEC before investing in this offering. The press release does not constitute an offer to sell securities.